论文部分内容阅读
目的探讨严重创伤后凝血病的早期诊断与新疗法治疗的疗效。方法选取我院2007年1月至2014年12月收治的严重创伤合并凝血病患者64例,外院紧急会诊救治患者9例作为研究对象。分为对照组和治疗组,对照组采用相关综合治疗,治疗组在综合治疗基础上,采用20AA高支链肝病复方氨基酸注射液(丰诺安)联用大剂量维生素B_6新疗法。观察患者15 d死亡率的变化。结果与对照组比较,治疗组死亡率得到显著降低,大出血一般在1.5~72 h逐步得到控制,最快的1例在静脉输入1 h就明显控制了大出血,肝功能都有明显好转。结论在综合治疗基础上采用20AA高支链肝病复方氨基酸注射液(丰诺安)联用大剂量B_6新疗法对救治严重创伤后凝血病患者效果明显。
Objective To investigate the early diagnosis of severe post-traumatic coagulopathy and new therapies. Methods Totally 64 cases of severe traumatic combined coagulopathy admitted to our hospital from January 2007 to December 2014 were selected, and 9 cases of emergency consultation and treatment of outside hospital were selected as the research object. Divided into the control group and treatment group, the control group using the relevant comprehensive treatment, the treatment group on the basis of comprehensive treatment, the use of 20AA high-branched-chain liver disease compound amino acid injection (Feng Nuo An) combined with high-dose vitamin B_6 new therapy. Observe the 15-day mortality rate of patients. Results Compared with the control group, the mortality of the treatment group was significantly reduced. The major bleeding was generally controlled gradually from 1.5 to 72 hours. The fastest one was obviously controlled after the intravenous infusion of 1 hour, and the liver function improved obviously. Conclusion Based on the comprehensive treatment, the combination of 20AA high-branched-chain liver disease compound amino acid injection (Fengnuo An) with high-dose B_6 new therapy is effective in treating post-traumatic coagulopathy patients.